Escalon Medical Corp. ESMC
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.73% | -11.60% | 1.17% | 1.04% | 0.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.73% | -11.60% | 1.17% | 1.04% | 0.54% |
| Cost of Revenue | 9.66% | -5.52% | 1.72% | -3.45% | -4.39% |
| Gross Profit | 1.06% | -18.97% | 0.46% | 7.02% | 7.09% |
| SG&A Expenses | 8.61% | 8.57% | 5.67% | 1.56% | 1.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.53% | 0.29% | 4.62% | 0.41% | -1.43% |
| Operating Income | -66.12% | -239.18% | -194.92% | 63.13% | 227.49% |
| Income Before Tax | 2,623.32% | 198.76% | -234.61% | 24.96% | 184.27% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3,703.41% | 198.76% | -234.61% | 24.96% | 184.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3,703.41% | 198.76% | -234.61% | 24.96% | 184.27% |
| EBIT | -66.12% | -239.18% | -194.92% | 63.13% | 227.49% |
| EBITDA | -60.37% | -225.29% | -165.25% | 89.73% | 392.98% |
| EPS Basic | 23,063.64% | 136.28% | -1,239.39% | -6.32% | 104.62% |
| Normalized Basic EPS | -43.82% | -255.36% | -235.26% | 25.22% | 183.96% |
| EPS Diluted | 9,157.14% | 158.60% | -6,166.67% | 7.88% | 88.24% |
| Normalized Diluted EPS | 32.20% | -312.70% | -720.69% | -154.78% | -11.32% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 18.86% | 1.59% | 19.53% | 45.23% | 45.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |